These findings revealed the tumor-specific overexpression of the transcription factor ATF5 with its underlying mechanisms in promoting tumor survival in CTCL, providing new insight into the understanding of CTCL’s pathology. Here, ATF5 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.